353 related articles for article (PubMed ID: 18642944)
1. Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins.
Li B; An HJ; Kirmiz C; Lebrilla CB; Lam KS; Miyamoto S
J Proteome Res; 2008 Sep; 7(9):3776-88. PubMed ID: 18642944
[TBL] [Abstract][Full Text] [Related]
2. A glycomics approach to the discovery of potential cancer biomarkers.
An HJ; Lebrilla CB
Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130
[TBL] [Abstract][Full Text] [Related]
3. Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer.
An HJ; Miyamoto S; Lancaster KS; Kirmiz C; Li B; Lam KS; Leiserowitz GS; Lebrilla CB
J Proteome Res; 2006 Jul; 5(7):1626-35. PubMed ID: 16823970
[TBL] [Abstract][Full Text] [Related]
4. Methods in enzymology: O-glycosylation of proteins.
Peter-Katalinić J
Methods Enzymol; 2005; 405():139-71. PubMed ID: 16413314
[TBL] [Abstract][Full Text] [Related]
5. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW
Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of glycosylation: structural determination of N- and O-linked glycans by mass spectrometry.
Harvey DJ
Expert Rev Proteomics; 2005 Jan; 2(1):87-101. PubMed ID: 15966855
[TBL] [Abstract][Full Text] [Related]
7. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis.
Zhao J; Qiu W; Simeone DM; Lubman DM
J Proteome Res; 2007 Mar; 6(3):1126-38. PubMed ID: 17249709
[TBL] [Abstract][Full Text] [Related]
8. Identification of hemoglobin-alpha and -beta subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer.
Woong-Shick A; Sung-Pil P; Su-Mi B; Joon-Mo L; Sung-Eun N; Gye-Hyun N; Young-Lae C; Ho-Sun C; Heung-Jae J; Chong-Kook K; Young-Wan K; Byoung-Don H; Hyun-Sun J
Cancer Sci; 2005 Mar; 96(3):197-201. PubMed ID: 15771624
[TBL] [Abstract][Full Text] [Related]
9. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma.
Hongsachart P; Huang-Liu R; Sinchaikul S; Pan FM; Phutrakul S; Chuang YM; Yu CJ; Chen ST
Electrophoresis; 2009 Apr; 30(7):1206-20. PubMed ID: 19294700
[TBL] [Abstract][Full Text] [Related]
10. Glycoproteomics of N-glycosylation by in-gel deglycosylation and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry mapping: application to congenital disorders of glycosylation.
Sagi D; Kienz P; Denecke J; Marquardt T; Peter-Katalinić J
Proteomics; 2005 Jul; 5(10):2689-701. PubMed ID: 15912511
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation status of the membrane protein CD9P-1.
André M; Morelle W; Planchon S; Milhiet PE; Rubinstein E; Mollicone R; Chamot-Rooke J; Le Naour F
Proteomics; 2007 Nov; 7(21):3880-95. PubMed ID: 17960739
[TBL] [Abstract][Full Text] [Related]
12. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans.
Chandrasekaran EV; Xue J; Neelamegham S; Matta KL
Carbohydr Res; 2006 Jun; 341(8):983-94. PubMed ID: 16545347
[TBL] [Abstract][Full Text] [Related]
13. Glycoproteomic survey of Mammillaria gracillis tissues grown in vitro.
Balen B; Krsnik-Rasol M; Zamfir AD; Milosević J; Vakhrushev SY; Peter-Katalinić J
J Proteome Res; 2006 Jul; 5(7):1658-66. PubMed ID: 16823973
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.
Gunawardana CG; Kuk C; Smith CR; Batruch I; Soosaipillai A; Diamandis EP
J Proteome Res; 2009 Oct; 8(10):4705-13. PubMed ID: 19663500
[TBL] [Abstract][Full Text] [Related]
15. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
16. Proteomic studies of early-stage and advanced ovarian cancer patients.
Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
[TBL] [Abstract][Full Text] [Related]
17. Characterization of serum biomarkers for detection of early stage ovarian cancer.
Kozak KR; Su F; Whitelegge JP; Faull K; Reddy S; Farias-Eisner R
Proteomics; 2005 Nov; 5(17):4589-96. PubMed ID: 16237736
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.
Moshkovskii SA; Serebryakova MV; Kuteykin-Teplyakov KB; Tikhonova OV; Goufman EI; Zgoda VG; Taranets IN; Makarov OV; Archakov AI
Proteomics; 2005 Sep; 5(14):3790-7. PubMed ID: 16121334
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG.
Saldova R; Royle L; Radcliffe CM; Abd Hamid UM; Evans R; Arnold JN; Banks RE; Hutson R; Harvey DJ; Antrobus R; Petrescu SM; Dwek RA; Rudd PM
Glycobiology; 2007 Dec; 17(12):1344-56. PubMed ID: 17884841
[TBL] [Abstract][Full Text] [Related]
20. [Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?].
Petri AL; Høgdall E; Engelholm SA; Christensen IJ; Kjaer SK; Høgdall CK
Ugeskr Laeger; 2007 Aug; 169(33):2614-9. PubMed ID: 17725906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
